866-997-4948(US-Canada Toll Free)

United States Calcium Channel Blockers Market Report 2018

Published By :

QYResearch

Published Date : May 2018

Category :

Pharmaceutical

No. of Pages : 99 Pages

In this report, the United States Calcium Channel Blockers market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Calcium Channel Blockers in these regions, from 2013 to 2025 (forecast).

United States Calcium Channel Blockers market competition by top manufacturers/players, with Calcium Channel Blockers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Selective Blockers
Non-Selective Blockers
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy

Table of Contents

United States Calcium Channel Blockers Market Report 2018
1 Calcium Channel Blockers Overview
1.1 Product Overview and Scope of Calcium Channel Blockers
1.2 Classification of Calcium Channel Blockers by Product Category
1.2.1 United States Calcium Channel Blockers Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Calcium Channel Blockers Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Selective Blockers
1.2.4 Non-Selective Blockers
1.3 United States Calcium Channel Blockers Market by Application/End Users
1.3.1 United States Calcium Channel Blockers Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Cardiomyopathy
1.4 United States Calcium Channel Blockers Market by Region
1.4.1 United States Calcium Channel Blockers Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Calcium Channel Blockers Status and Prospect (2013-2025)
1.4.3 Southwest Calcium Channel Blockers Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Calcium Channel Blockers Status and Prospect (2013-2025)
1.4.5 New England Calcium Channel Blockers Status and Prospect (2013-2025)
1.4.6 The South Calcium Channel Blockers Status and Prospect (2013-2025)
1.4.7 The Midwest Calcium Channel Blockers Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Calcium Channel Blockers (2013-2025)
1.5.1 United States Calcium Channel Blockers Sales and Growth Rate (2013-2025)
1.5.2 United States Calcium Channel Blockers Revenue and Growth Rate (2013-2025)

2 United States Calcium Channel Blockers Market Competition by Players/Suppliers
2.1 United States Calcium Channel Blockers Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Calcium Channel Blockers Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Calcium Channel Blockers Average Price by Players/Suppliers (2013-2018)
2.4 United States Calcium Channel Blockers Market Competitive Situation and Trends
2.4.1 United States Calcium Channel Blockers Market Concentration Rate
2.4.2 United States Calcium Channel Blockers Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Calcium Channel Blockers Manufacturing Base Distribution, Sales Area, Product Type

3 United States Calcium Channel Blockers Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Calcium Channel Blockers Sales and Market Share by Region (2013-2018)
3.2 United States Calcium Channel Blockers Revenue and Market Share by Region (2013-2018)
3.3 United States Calcium Channel Blockers Price by Region (2013-2018)

4 United States Calcium Channel Blockers Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Calcium Channel Blockers Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Calcium Channel Blockers Revenue and Market Share by Type (2013-2018)
4.3 United States Calcium Channel Blockers Price by Type (2013-2018)
4.4 United States Calcium Channel Blockers Sales Growth Rate by Type (2013-2018)

5 United States Calcium Channel Blockers Sales (Volume) by Application (2013-2018)
5.1 United States Calcium Channel Blockers Sales and Market Share by Application (2013-2018)
5.2 United States Calcium Channel Blockers Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Calcium Channel Blockers Players/Suppliers Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Calcium Channel Blockers Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Aventis
6.2.2 Calcium Channel Blockers Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Aventis Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Searle
6.3.2 Calcium Channel Blockers Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Searle Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bayer
6.4.2 Calcium Channel Blockers Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bayer Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Calcium Channel Blockers Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Knoll Pharmaceuticals
6.6.2 Calcium Channel Blockers Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Knoll Pharmaceuticals Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Wyeth-Ayerst
6.7.2 Calcium Channel Blockers Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Wyeth-Ayerst Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 AstraZeneca
6.8.2 Calcium Channel Blockers Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 AstraZeneca Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.2 Calcium Channel Blockers Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Sanofi
6.10.2 Calcium Channel Blockers Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sanofi Calcium Channel Blockers Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview

7 Calcium Channel Blockers Manufacturing Cost Analysis
7.1 Calcium Channel Blockers Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Calcium Channel Blockers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Calcium Channel Blockers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Calcium Channel Blockers Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Calcium Channel Blockers Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Calcium Channel Blockers Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Calcium Channel Blockers Sales Volume Forecast by Type (2018-2025)
11.3 United States Calcium Channel Blockers Sales Volume Forecast by Application (2018-2025)
11.4 United States Calcium Channel Blockers Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Calcium Channel Blockers
Figure United States Calcium Channel Blockers Market Size (K MT) by Type (2013-2025)
Figure United States Calcium Channel Blockers Sales Volume Market Share by Type (Product Category) in 2017
Figure Selective Blockers Product Picture
Figure Non-Selective Blockers Product Picture
Figure United States Calcium Channel Blockers Market Size (K MT) by Application (2013-2025)
Figure United States Sales Market Share of Calcium Channel Blockers by Application in 2017
Figure Hypertension Examples
Table Key Downstream Customer in Hypertension
Figure Coronary Artery Disease Examples
Table Key Downstream Customer in Coronary Artery Disease
Figure Arrhythmia Examples
Table Key Downstream Customer in Arrhythmia
Figure Cardiomyopathy Examples
Table Key Downstream Customer in Cardiomyopathy
Figure United States Calcium Channel Blockers Market Size (Million USD) by Region (2013-2025)
Figure The West Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Calcium Channel Blockers Sales (K MT) and Growth Rate (2013-2025)
Figure United States Calcium Channel Blockers Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Calcium Channel Blockers Market Major Players Product Sales Volume (K MT) (2013-2018)
Table United States Calcium Channel Blockers Sales (K MT) of Key Players/Suppliers (2013-2018)
Table United States Calcium Channel Blockers Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Calcium Channel Blockers Sales Share by Players/Suppliers
Figure 2017 United States Calcium Channel Blockers Sales Share by Players/Suppliers
Figure United States Calcium Channel Blockers Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Calcium Channel Blockers Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Calcium Channel Blockers Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Calcium Channel Blockers Revenue Share by Players/Suppliers
Figure 2017 United States Calcium Channel Blockers Revenue Share by Players/Suppliers
Table United States Market Calcium Channel Blockers Average Price (USD/MT) of Key Players/Suppliers (2013-2018)
Figure United States Market Calcium Channel Blockers Average Price (USD/MT) of Key Players/Suppliers in 2017
Figure United States Calcium Channel Blockers Market Share of Top 3 Players/Suppliers
Figure United States Calcium Channel Blockers Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Calcium Channel Blockers Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Calcium Channel Blockers Product Category
Table United States Calcium Channel Blockers Sales (K MT) by Region (2013-2018)
Table United States Calcium Channel Blockers Sales Share by Region (2013-2018)
Figure United States Calcium Channel Blockers Sales Share by Region (2013-2018)
Figure United States Calcium Channel Blockers Sales Market Share by Region in 2017
Table United States Calcium Channel Blockers Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Calcium Channel Blockers Revenue Share by Region (2013-2018)
Figure United States Calcium Channel Blockers Revenue Market Share by Region (2013-2018)
Figure United States Calcium Channel Blockers Revenue Market Share by Region in 2017
Table United States Calcium Channel Blockers Price (USD/MT) by Region (2013-2018)
Table United States Calcium Channel Blockers Sales (K MT) by Type (2013-2018)
Table United States Calcium Channel Blockers Sales Share by Type (2013-2018)
Figure United States Calcium Channel Blockers Sales Share by Type (2013-2018)
Figure United States Calcium Channel Blockers Sales Market Share by Type in 2017
Table United States Calcium Channel Blockers Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Calcium Channel Blockers Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Calcium Channel Blockers by Type (2013-2018)
Figure Revenue Market Share of Calcium Channel Blockers by Type in 2017
Table United States Calcium Channel Blockers Price (USD/MT) by Types (2013-2018)
Figure United States Calcium Channel Blockers Sales Growth Rate by Type (2013-2018)
Table United States Calcium Channel Blockers Sales (K MT) by Application (2013-2018)
Table United States Calcium Channel Blockers Sales Market Share by Application (2013-2018)
Figure United States Calcium Channel Blockers Sales Market Share by Application (2013-2018)
Figure United States Calcium Channel Blockers Sales Market Share by Application in 2017
Table United States Calcium Channel Blockers Sales Growth Rate by Application (2013-2018)
Figure United States Calcium Channel Blockers Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Pfizer Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Pfizer Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Pfizer Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Aventis Basic Information List
Table Aventis Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Aventis Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Aventis Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Aventis Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Searle Basic Information List
Table Searle Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Searle Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Searle Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Searle Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Bayer Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Bayer Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Bayer Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Knoll Pharmaceuticals Basic Information List
Table Knoll Pharmaceuticals Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Knoll Pharmaceuticals Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Knoll Pharmaceuticals Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Knoll Pharmaceuticals Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Wyeth-Ayerst Basic Information List
Table Wyeth-Ayerst Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Wyeth-Ayerst Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Wyeth-Ayerst Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Wyeth-Ayerst Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure AstraZeneca Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Novartis Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Novartis Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Novartis Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Calcium Channel Blockers Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2013-2018)
Figure Sanofi Calcium Channel Blockers Sales Growth Rate (2013-2018)
Figure Sanofi Calcium Channel Blockers Sales Market Share in United States (2013-2018)
Figure Sanofi Calcium Channel Blockers Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Calcium Channel Blockers
Figure Manufacturing Process Analysis of Calcium Channel Blockers
Figure Calcium Channel Blockers Industrial Chain Analysis
Table Raw Materials Sources of Calcium Channel Blockers Major Players/Suppliers in 2017
Table Major Buyers of Calcium Channel Blockers
Table Distributors/Traders List
Figure United States Calcium Channel Blockers Sales Volume (K MT) and Growth Rate Forecast (2018-2025)
Figure United States Calcium Channel Blockers Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Calcium Channel Blockers Price (USD/MT) Trend Forecast (2018-2025)
Table United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Type (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Type in 2025
Table United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Application (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Application in 2025
Table United States Calcium Channel Blockers Sales Volume (K MT) Forecast by Region (2018-2025)
Table United States Calcium Channel Blockers Sales Volume Share Forecast by Region (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume Share Forecast by Region (2018-2025)
Figure United States Calcium Channel Blockers Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *